Status:

TERMINATED

Combination of Taliderm® and Vacuum-assisted Closure (VAC) for Treatment of Pressure Ulcers

Lead Sponsor:

University Hospital, Basel, Switzerland

Collaborating Sponsors:

Marine Polymer Technologies, Inc.

Conditions:

Wounds

Pressure Ulcer

Eligibility:

All Genders

18+ years

Phase:

EARLY_PHASE1

Brief Summary

Background: The wound healing promoting effect of negative wound pressure therapies (NWPT) takes place at the wound foam interface. Implementation of bioactive substances at this site represents a maj...

Eligibility Criteria

Inclusion

  • Ischial/sacral Pressure ulcer between 4 and 15cm diameter
  • Greater than or equal to 18 years of age
  • Ability to obtain informed consent

Exclusion

  • Connective tissue disorders
  • Immunosuppression, Hemodialysis, Steroids
  • Pregnancy
  • Sepsis

Key Trial Info

Start Date :

February 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT02237287

Start Date

February 1 2011

End Date

August 1 2012

Last Update

September 29 2015

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University Hospital Basel

Basel, Switzerland, 4031

2

Swiss Paraplegic Centre Nottwil

Nottwil, Switzerland, 6207

Combination of Taliderm® and Vacuum-assisted Closure (VAC) for Treatment of Pressure Ulcers | DecenTrialz